Chinese Traditional and Herbal Drugs
|
2025, 56(18): 6580-6590
Preparation and in vitro and in vivo evaluation of indigo-indirubin nano-foam aerosol for rectum
Full
WANG Cheng1, SHENG Hua1, YANG Ming2, ZHANG Dingkun3, HE Yanan3, SHENG Yanmei1, HAN Li4, XIE Xingliang1,3
Affiliations
1 School of Pharmacy, Chengdu Medical College, Chengdu 610500, China; 2 State Key Laboratory for the Chinese Medicine Modernization of Classical and Famous Prescriptions, Jiangxi University of Chinese Medicine, Nanchang 330004, China; 3 College of Modern Traditional Chinese Medicine Industry/Tianfu Traditional Chinese Medicine Innovation Port, Chengdu University of Traditional Chinese Medicine, Sichuan Provincial Engineering Research Center for Secondary Innovative Development of Classic Famous Formulas, Chengdu 611930, China; 4 State Key Laboratory of Southwestern Chinese Medicine Resources, School of pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
About Author:
国家自然科学基金面上项目 (82173976)
doi: 10.7501/j.issn.0253-2670.2025.18.008
Outline
Objective To prepare a rectal indigo-indirubin nano-foam aerosol (Ind/INB-NFA) for ulcerative colitis (UC) and evaluate its performance through in vitro and in vivo studies. Methods Indigo-indirubin nanosuspensions (Ind/INB-NS) was prepared by ball milling technology and characterized for particle size, polydispersity index (PDI), ζ potential, stability, micromorphology, infrared absorption, and in vitro release. Ind/INB-NFA was optimized using central composite design-response surface methodology (CCD-RSM), with Ind/INB-NS as the intermediate. Its physicochemical properties and mucosal permeability were evaluated. A dextran sulfate sodium (DSS)-induced UC rat model was established to assess therapeutic effects through body weight, disease activity index (DAI) score, colorectal length, colon weight coefficient, and histopathological scoring. Results Ind/INB-NS had a particle size of (117.5 ± 0.8) nm, PDI of 0.249 ± 0.013, and ζ potential of (−32.3 ± 1.0) mV. It remained stable for 60 d. Fourier transform infrared spectroscopy (FTIS) showed no significant changes during the nanonization process. Compared with raw active pharmaceutical ingredients (APIs), the 12 h in vitro release of indigo and indirubin from nanosuspensions increased by 30.46% and 21.39%, respectively. The optimal formulation of the foam base solution contained 28.25% Ind/INB-NS, 2.26% sodium lauroyl sarcosinate, 1.00% Brij® S10, 1.50% cetyl alcohol, 1.26% cetearyl alcohol, and a 4.72:5.28 propylene glycol/water ratio. The propellant HFA-134a content in this formulation was 20%. The ejecta formed light blue, finely textured foam with an expansion ratio of 14.38 ± 1.10, which maintained stable morphology with only (0.23 ± 0.03) cm of flow displacement over 4 h. Compared with raw APIs, mucosal permeation rates of indigo and indirubin increased by 60.05% and 14.53% at 24 h. The foam aerosol alleviated diarrhea and hematochezia in DSS-induced UC rats. It significantly reduced DAI scores (P < 0.01) and colon weight coefficients (P < 0.01), increased colorectal length (P < 0.05), diminished inflammatory infiltration (P < 0.01) ,and reduced the pathological injury score of colon tissue (P < 0.01). Conclusion The novel Ind/INB-NFA was successfully developed, which is conducive to giving full play to the therapeutic effect of indigo and indirubin in the treatment of UC and has a good application prospect.
ulcerative colitis
/
indigo
/
indirubin
/
nanosuspension
/
nano-foam aerosol
/
pharmacodynamics
/
ball milling technology
/
central composite design-response surface methodology
王成, 盛华, 杨明, 张定堃, 贺亚男, 盛艳梅, 韩丽, 谢兴亮.
直肠用靛蓝-靛玉红纳米泡沫气雾剂的制备及体内外评价.
中草药,
2025
, 56
(18)
: 6580
-6590
.
DOI: 10.7501/j.issn.0253-2670.2025.18.008
WANG Cheng, SHENG Hua, YANG Ming, ZHANG Dingkun, HE Yanan, SHENG Yanmei, HAN Li, XIE Xingliang.
Preparation and in vitro and in vivo evaluation of indigo-indirubin nano-foam aerosol for rectum[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(18)
: 6580
-6590
.
DOI: 10.7501/j.issn.0253-2670.2025.18.008
Year 2025 volume 56 Issue 18
43
0
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.18.008
- Receive Date:2025-04-17
- Online Date:2026-11-12